We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Talampanel for Amyotrophic Lateral Sclerosis (ALS) (ALS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00696332
Recruitment Status : Completed
First Posted : June 12, 2008
Last Update Posted : October 21, 2011
Information provided by (Responsible Party):
Teva Pharmaceutical Industries

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : April 2010
  Study Completion Date : May 2010
  Certification or Request for Extension to Delay Results Submission: August 16, 2011